Mint Explainer Why Indian Pharma Is Spooked By Trump's Latest Drug Policy

8hrs 17mins 👁 4

US President Donald Trump plans to nbsp;slash prices of prescription drugs in the country by 30-80%. How will this impact Indian drugmakers, who mostly ship relatively inexpensive generic medicines to the US? Mint explains.

Click Here To Visit Source

Recommended For You

Rate transmission uneven despite liquidity comfort

Indias insolvency law has bankers going bald

PSU banks may take a hit on margins as interest ra

Centre plans strict timelines, penalties for miner

Summer getaways get costlier: Airfares up 10-15% o

Sumitomo deal gives clarity on SBI's stake: Yes Ba

How Apple became dependent on China for large chun

UP govt targets 12 pc increase in Kharif productio

PNB takes aim at 3-4 specific sectors as it gears

Neo Wealth Management appoints Shajikumar Devakar

Banking for minors: A progress whose time has come

Circular economy: What Hyderabad can teach the res

Mint Explainer: Why Indian Pharma Is Spooked By Trump's Latest Drug Policy